Wednesday, 29 July 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
Car trade Tech Limited Partners With… ▲ Capex & Future Plans ACME Solar Secures ₹3,404 Crore Long-Term… ▲ Capex & Future Plans Inox Wind Secures ₹1,600 Crore Turnkey… ▲ Order Book Stock Watch Today: Nifty, Sensex &… ▲ Market News / Economy Indo MIM IPO Allotment Status: Check… ▲ Ipos Tata Capital Q1 Results: PAT Soars… ▲ Results Details BlueStone Jewellery and Lifestyle Reports Strong… ▲ Results Details
Home / Order Book / Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials
OB · Order Book

Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials

Panacea Biotec Lands ₹127 Crore bOPV Order:Contextualizing Recent Mega Contracts in India’s Industrials

Panacea Biotec Limited: bOPV Vaccine Supply Order

Panacea Biotec has secured a domestic contract for the supply of the bivalent oral polio vaccine (bOPV). The key details are as follows:

  • Order Value: ₹127.20 crore

  • Execution Timeline: The supply is to be delivered in tranches over 90 to 480 days following the Letter of Acceptance (LOA) issued on October 8, 2025

  • Contracting Authority: The order has been awarded by the Central Medical Services Society (CMSS), under the Ministry of Health & Family Welfare, Government of India